CY2265B1 - Pharmaceutical composition for the oral administration of flavonoids - Google Patents

Pharmaceutical composition for the oral administration of flavonoids

Info

Publication number
CY2265B1
CY2265B1 CY0200016A CY0200016A CY2265B1 CY 2265 B1 CY2265 B1 CY 2265B1 CY 0200016 A CY0200016 A CY 0200016A CY 0200016 A CY0200016 A CY 0200016A CY 2265 B1 CY2265 B1 CY 2265B1
Authority
CY
Cyprus
Prior art keywords
flavonoids
pharmaceutical composition
oral administration
micronised
pref
Prior art date
Application number
CY0200016A
Inventor
De Barochez Bruno Huet
Noel Piot
Alain Cuine
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of CY2265B1 publication Critical patent/CY2265B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Abstract

Oral compsns. contain a rutaceous flavonoid, partic. micronised diosmin (I), as an effervescent granulate in the form of tablets or sachets. The compsn. pref. comprises 0.1-5 g (I) which is pref. micronised to a particle size of 0.1-10 mu m. The effervescent formulation is achieved by use of a carboxylic acid and one or more carbonates. Other ingredients include sweeteners, flavourings and carriers. The small amt. of water present in (I) is used to start a single phase granulation process.
CY0200016A 1994-11-08 2002-04-12 Pharmaceutical composition for the oral administration of flavonoids CY2265B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9413336A FR2726469B1 (en) 1994-11-08 1994-11-08 PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION OF FLAVONOIDS

Publications (1)

Publication Number Publication Date
CY2265B1 true CY2265B1 (en) 2003-07-04

Family

ID=9468588

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0200016A CY2265B1 (en) 1994-11-08 2002-04-12 Pharmaceutical composition for the oral administration of flavonoids

Country Status (18)

Country Link
EP (1) EP0711560B1 (en)
JP (1) JP3022952B2 (en)
KR (1) KR960016901A (en)
CN (1) CN1131538A (en)
AT (1) ATE202480T1 (en)
AU (1) AU706027B2 (en)
CA (1) CA2162299C (en)
CY (1) CY2265B1 (en)
DE (1) DE69521477T2 (en)
DK (1) DK0711560T3 (en)
ES (1) ES2160145T3 (en)
FI (1) FI117123B (en)
FR (1) FR2726469B1 (en)
GR (1) GR3036244T3 (en)
NO (1) NO311402B1 (en)
NZ (1) NZ280418A (en)
PT (1) PT711560E (en)
ZA (1) ZA959473B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1011151A3 (en) * 1997-05-13 1999-05-04 Jose Remacle Use of a pharmaceutical composition for treating and / or preventing ischemia.
US6350470B1 (en) * 1998-04-29 2002-02-26 Cima Labs Inc. Effervescent drug delivery system for oral administration
JP4273277B2 (en) * 1999-06-30 2009-06-03 大塚製薬株式会社 Oligosaccharide supplement composition
JP2001158796A (en) * 1999-11-30 2001-06-12 Toyo Seito Kk Method for producing alpha-glucosyldiosmin and flavonoid composition
FR2845597B1 (en) * 2002-10-11 2005-03-11 Innothera Lab Sa DRY ORAL FORMULATION CONTAINING DIOSMINE AS A PHARMACEUTICAL FORM OF A TABLET TO BE CROQUERED
DK1556021T3 (en) 2002-10-24 2008-04-28 Immupharm As Pharmaceutical compositions comprising flavonoids and menthol as well as methods of treatment using said compositions
AT501682A1 (en) 2005-01-14 2006-10-15 Hermine Dr Engl METHOD FOR PRODUCING AN ACTIVE SUBSTANCE MIXTURE
ITMI20050517A1 (en) 2005-03-30 2006-09-30 Therapicon Srl PHARMACEUTICAL COMPOSITION OF A TYPICAL MICROCRYSTALLINE FRACTION OF FLAVONOIDS
ITMI20051942A1 (en) * 2005-10-14 2007-04-15 S I I T S R L Servizio Interna GALATTOGENIC COMPOSITIONS BASED ON SILIMARINE
US20070122363A1 (en) * 2005-11-26 2007-05-31 Giniger Martin S Corporeal delivery of carotenoids
MX2007011002A (en) * 2007-09-07 2009-03-09 World Trade Imp Export Wtie Ag Pharmaceutical composition combining various venotonic and vasoprotective agents for the treatment of chronic venous insufficiency.
CA2769278A1 (en) * 2009-08-10 2011-02-17 Stokely-Van Camp, Inc. Method for suspending a flavonoid in a beverage
MD3987C2 (en) * 2009-09-03 2010-07-31 Георге АНГЕЛИЧ Use of Diosmine for the treatment of advancing hepatic cirrhosis associated with cardiac insufficiency
MD3986C2 (en) * 2009-09-23 2010-07-31 Георге АНГЕЛИЧ Use of Diosmine for the treatment of portal gastropathies in the hepatic cirrhosis
MD4231C1 (en) * 2012-11-08 2014-01-31 Георге АНГЕЛИЧ Medicament based on troxerutin and carbazochrome for the treatment of portal gastropathies in hepatic cirrhosis
MD4232C1 (en) * 2012-11-08 2014-01-31 Георге АНГЕЛИЧ Medicament based on troxerutin and carbazochrome for the treatment of progressive hepatic cirrhosis associated with heart failure
FR2999934B1 (en) * 2012-12-21 2015-02-20 Servier Lab PHARMACEUTICAL COMPOSITION IN THE FORM OF AN ORAL SUSPENSION COMPRISING A FLAVONOIC FRACTION AND XANTHAN GUM
AU2015316552C1 (en) 2014-09-17 2018-08-23 Steerlife India Private Limited Effervescent composition and method of making it
WO2017098481A1 (en) 2015-12-12 2017-06-15 Steerlife India Private Limited Effervescent compositions of metformin and processes for preparation thereof
FR3083980B1 (en) 2018-07-20 2021-04-16 Servier Lab PHARMACEUTICAL COMPOSITION IN THE FORM OF A CHEWABLE TABLET OF DIOSMINE OR A FLAVONOIC FRACTION
US10639294B2 (en) 2018-10-02 2020-05-05 Janssen Pharmaceutica Nv Pharmaceutical compositions comprising a hydroxyethylquercetin glucuronide metabolite
US11304968B2 (en) 2018-11-16 2022-04-19 Janssen Pharmaceutica Nv Pharmaceutical compositions comprising a hydroxyethylquercetin glucuronide
WO2021123341A1 (en) 2019-12-20 2021-06-24 Krka, D.D., Novo Mesto Composition comprising diosmin

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6967M (en) * 1968-01-22 1969-05-19
JPS52156913A (en) * 1976-06-21 1977-12-27 Toko Yakuhin Kogyo Kk Production of injectionable medicine
RO81345B1 (en) * 1980-07-28 1983-02-28 Nicolae Oita Medicament for peripheral cardiovascular insufficiency
US5096887A (en) * 1984-03-01 1992-03-17 Lamorna Investments Proprietary Limited Treatment of high protein oedemas
FR2577437A1 (en) * 1985-02-21 1986-08-22 Corbiere Jerome New process for dissolving chemical compounds and aqueous preparations thus obtained
IT1201149B (en) * 1987-01-14 1989-01-27 Indena Spa BIOFLAVONOID COMPLEXES WITH PHOSPHOLIPIDS, THEIR PREPARATION, USE AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS
FR2634376B1 (en) * 1988-07-21 1992-04-17 Farmalyoc NOVEL SOLID AND POROUS UNIT FORM COMPRISING MICROPARTICLES AND / OR NANOPARTICLES, AS WELL AS ITS PREPARATION
FR2661610B1 (en) * 1990-05-02 1994-09-30 Rhone Poulenc Sante NOVEL LYOPHILIZED FORM OF DIOSMINE AND ITS PREPARATION.
FR2661830B1 (en) * 1990-05-11 1992-09-04 Corbiere Jerome NOVEL PHARMACEUTICAL COMPOSITIONS BASED ON FLAVONOSIDE.
FR2668705A1 (en) * 1990-11-06 1992-05-07 Bouchara Sa Novel skin preparations having a phlebotonic action and process for preparing them

Also Published As

Publication number Publication date
CA2162299A1 (en) 1996-05-09
ZA959473B (en) 1996-05-15
GR3036244T3 (en) 2001-10-31
NO311402B1 (en) 2001-11-26
JPH08208469A (en) 1996-08-13
AU706027B2 (en) 1999-06-10
CA2162299C (en) 2008-09-09
KR960016901A (en) 1996-06-17
EP0711560A1 (en) 1996-05-15
FI117123B (en) 2006-06-30
FR2726469A1 (en) 1996-05-10
ATE202480T1 (en) 2001-07-15
AU3669595A (en) 1996-05-16
PT711560E (en) 2001-10-30
EP0711560B1 (en) 2001-06-27
FI955310A (en) 1996-05-09
DE69521477D1 (en) 2001-08-02
NZ280418A (en) 1997-03-24
DE69521477T2 (en) 2002-04-18
CN1131538A (en) 1996-09-25
NO954455D0 (en) 1995-11-07
NO954455L (en) 1996-05-09
JP3022952B2 (en) 2000-03-21
FR2726469B1 (en) 1996-12-13
ES2160145T3 (en) 2001-11-01
DK0711560T3 (en) 2001-09-03
FI955310A0 (en) 1995-11-06

Similar Documents

Publication Publication Date Title
GR3036244T3 (en) Pharmaceutical composition for the oral administration of flavonoids
AU613517B2 (en) Morphine-containing composition
HUT49629A (en) Process for producing peptide-boronic acid derivatives inhibiting trypsin-like proteases and pharmaceutical compositions comprising such compounds as active ingredient
IL107221A0 (en) Carboxylic acid derivatives, pharmaceutical compositions containing them and processes for their preparation
HUT53068A (en) Process for producing benzoic acid and phenylacetic acid derivatives and pharmaceutical compositions comprising such active ingredient
CA2103793A1 (en) Solvent system to be enclosed in capsules
HUT64065A (en) Process for producing quinolone- and naphthyridonecarboxylic acid derivatives and pharmaceutical compositions comprising same as active ingredient
IL107956A0 (en) Carboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
ATE158504T1 (en) EFFORTABLE MIXTURES CONTAINING IBUPROFEN AND METHODS
HUT61024A (en) Process for producing 10(1-hydroxyethyl)-11-oxo-1-aza-tricyclo/7.2.0.0.3.8/undex-2-ene-2-carboxylic acid esters and pharmaceutical compositions comprising same as active ingredient
HUT54166A (en) Process for producing 1,1-dioxocefem-4-carbothiol acid derivatives and pharmaceutical compositions comprising same as active ingredient
IL87876A0 (en) Catechol carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
DE3266072D1 (en) Method for the oral administration of substances in the form of liposomes, and relative pharmaceutical compositions
NO911892D0 (en) PROCEDURE FOR PREPARATION AND USE AS MEDICINES OF ALFA-OXOPYRROL (2,3-B) INDOLEDIC ACETIC ACIDS, ESTERS, AMIDES AND RELATED ANALOGS.
JPS5764610A (en) Pharmaceutical for rectal administration
ITMI920903A1 (en) PHARMACEUTICAL COMPOSITIONS ADMINISTRABLE BY ORAL TO TARGET RELEASE CONTAINING URSODEXOXYOLIC ACID AND CHENODEXOXYOLIC ACID.